Novel Genetic Causes of Gastrointestinal Polyposis Syndromes

References

• Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66(3):589–600. doi:10.1016/0092-8674(81)90021-0
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science (New York, NY). 1991;253(5020):661–665. doi:10.1126/science.1651562
   Google Scholar
• Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991;66(3):601–613. doi:10.1016/0092-8674(81)90022-2
   Web of Science ®Google Scholar
• Palles C, Cazier J-B, Howarth KM, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 2013;45:136–144. doi:10.1038/ng.2503
   PubMed Web of Science ®Google Scholar
• Buchanan DD, Stewart JR, Clendenning M, et al. Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genetics Med. 2018;20:890–895. doi:10.1038/gim.2017.185
   Web of Science ®Google Scholar
• Palles C, Martin L, Domingo E, et al. The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management. Fam Cancer. 2021. doi:10.1007/s10689-021-00256-y
   Web of Science ®Google Scholar
• Magrin L, Fanale D, Brando C, et al. POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes. Oncogene. 2021;40(40):5893–5901. doi:10.1038/s41388-021-01984-2
   Web of Science ®Google Scholar
• Spier I, Holzapfel S, Altmüller J, et al. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer. 2015;137(2):320–331. doi:10.1002/ijc.29396
   PubMed Web of Science ®Google Scholar
• Logan CV, Murray JE, Parry DA, et al. DNA polymerase epsilon deficiency causes IMAGe syndrome with variable immunodeficiency. Am J Hum Genet. 2018;103(6):1038–1044.
   Web of Science ®Google Scholar
• Pachlopnik Schmid J, Lemoine R, Nehme N, et al. Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS syndrome”). J Exp Med. 2012;209(13):2323–2330. doi:10.1084/jem.20121303
   Web of Science ®Google Scholar
• Eason C, Aleisa A, Jones JR, Prijoles EJ, Wine Lee L. Filling in the gaps on FILS syndrome: a case report and literature review. Pediatr Dermatol. 2020;37(5):915–917. doi:10.1111/pde.14274
   Web of Science ®Google Scholar
• Weedon MN, Ellard S, Prindle MJ, et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet. 2013;45(8):947–950. doi:10.1038/ng.2670
   PubMed Web of Science ®Google Scholar
• Elouej S, Beleza-Meireles A, Caswell R, et al. Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). Metabolism. 2017;71:213–225. doi:10.1016/j.metabol.2017.03.011
   PubMed Web of Science ®Google Scholar
• Lessel D, Hisama FM, Szakszon K, et al. POLD1 germline mutations in patients initially diagnosed with Werner syndrome. Hum Mutat. 2015;36(11):1070–1079. doi:10.1002/humu.22833
   PubMed Web of Science ®Google Scholar
• Wimmer K, Beilken A, Nustede R, et al. A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Fam Cancer. 2017;16:67–71. doi:10.1007/s10689-016-9925-1
   Web of Science ®Google Scholar
• Lindsay H, Scollon S, Reuther J, et al. Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency. Cold Spring Harbor Mol Case Studies. 2019;5:a004499.
   Web of Science ®Google Scholar
• Li J, Woods SL, Healey S, et al. Point mutations in Exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016;98(5):830–842. doi:10.1016/j.ajhg.2016.03.001
   PubMed Web of Science ®Google Scholar
• Worthley DL, Phillips KD, Wayte N, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61(5):774–779. doi:10.1136/gutjnl-2011-300348
   PubMed Web of Science ®Google Scholar
• Tacheci I, Repak R, Podhola M, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - A Helicobacter-opposite point. Best Pract Res Clin Gastroenterol. 2021;50-51:101728. doi:10.1016/j.bpg.2021.101728
   Web of Science ®Google Scholar
• Weren RD, Ligtenberg MJ, Kets CM, et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet. 2015;47:668–671. doi:10.1038/ng.3287
   Web of Science ®Google Scholar
• Terradas M, Munoz-Torres PM, Belhadj S, et al. Contribution to colonic polyposis of recently proposed predisposing genes and assessment of the prevalence of NTHL1- and MSH3-associated polyposes. Hum Mutat. 2019;40(11):1910–1923. doi:10.1002/humu.23853
   Web of Science ®Google Scholar
• Rivera B, Castellsague E, Bah I, van Kempen LC, Foulkes WD. Biallelic NTHL1 Mutations in a Woman with Multiple Primary Tumors. N Engl J Med. 2015(373):1985–1986.
   Web of Science ®Google Scholar
• Das L, Quintana VG, Sweasy JB. NTHL1 in genomic integrity, aging and cancer. DNA Repair (Amst). 2020;93:102920. doi:10.1016/j.dnarep.2020.102920
   Web of Science ®Google Scholar
• Weren RD, Ligtenberg MJ, Geurts van kessel A, De voer RM, Hoogerbrugge N, Kuiper RP. NTHL1 and MUTYH polyposis syndromes: two sides of the same coin? J Pathol. 2018;244(2):135–142. doi:10.1002/path.5002
   Web of Science ®Google Scholar
• Grolleman JE, de Voer RM, Elsayed FA, et al. Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype. Cancer Cell. 2019;35:256–266e255.
   Web of Science ®Google Scholar
• Belhadj S, Quintana I, Mur P, et al. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas. Sci Rep. 2019;9:9020. doi:10.1038/s41598-019-45281-1
   Web of Science ®Google Scholar
• Elsayed FA, Grolleman JE, Ragunathan A, Buchanan DD, van Wezel T, de Voer RM. Monoallelic NTHL1 loss-of-function variants and risk of polyposis and colorectal cancer. Gastroenterology. 2020;159(6):2241–2243.e2246. doi:10.1053/j.gastro.2020.08.042
   Web of Science ®Google Scholar
• Salo-Mullen EE, Maio A, Mukherjee S, et al. Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population. JCO Precis Oncol. 2021;5:455.
   Web of Science ®Google Scholar
• Adam R, Spier I, Zhao B, et al. Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet. 2016;99:337–351. doi:10.1016/j.ajhg.2016.06.015
   PubMed Web of Science ®Google Scholar
• Terradas M, Munoz-Torres PM, Belhadj S, et al. Contribution to colonic polyposis of recently proposed predisposing genes and assessment of the prevalence of NTHL1- and MSH3-associated polyposes. Hum Mutat. 2019(40):1910–1923.
   Web of Science ®Google Scholar
• Olkinuora A, Nieminen TT, Martensson E, et al. Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition. Genetics Med. 2019(21):1868–1873.
   PubMed Web of Science ®Google Scholar
• Nawaz S, Ullah MI, Hamid BS, et al. A loss-of-function variant in DNA mismatch repair gene MLH3 underlies severe oligozoospermia. J Hum Genet. 2021;66(7):725–730. doi:10.1038/s10038-021-00907-z
   Web of Science ®Google Scholar
• Chen S, Wang G, Zheng X, et al. Whole-exome sequencing of a large Chinese azoospermia and severe oligospermia cohort identifies novel infertility causative variants and genes. Hum Mol Genet. 2020;29(14):2451–2459. doi:10.1093/hmg/ddaa101
   PubMed Web of Science ®Google Scholar
• Valle L, de Voer RM, Goldberg Y, et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol Aspects Med. 2019;69:10–26. doi:10.1016/j.mam.2019.03.001
   PubMed Web of Science ®Google Scholar
• Tricarico R, Cortellino S, Riccio A, et al. Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget. 2015;6(40):42892–42904. doi:10.18632/oncotarget.5740
   Google Scholar
• Sanders MA, Chew E, Flensburg C, et al. MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML. Blood. 2018;132(14):1526–1534. doi:10.1182/blood-2018-05-852566
   PubMed Web of Science ®Google Scholar
• Palles C, Chew E, Grolleman JE, et al. Germline loss-of-function variants in the base-excision repair gene MBD4 cause a Mendelian recessive syndrome of adenomatous colorectal polyposis and acute myeloid leukaemia. bioRxiv. 2021. doi:10.1101/2021.04.27.441137
   Google Scholar
• Tanakaya K, Kumamoto K, Tada Y, et al. A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and early‑onset cancer: a case report. Oncol Rep. 2019;42(3):1133–1140.
   Web of Science ®Google Scholar
• Fousekis FS, Mitselos IV, Christodoulou DK. Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature. Am J Transl Res. 2021;13(6):5786–5795.
   Web of Science ®Google Scholar
• Buchanan DD, Clendenning M, Zhuoer L, et al. Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study. Gut. 2017;66:1170–1172. doi:10.1136/gutjnl-2016-312773
   Web of Science ®Google Scholar
• Gala MK, Mizukami Y, Le LP, et al. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology. 2014;146:520–529. doi:10.1053/j.gastro.2013.10.045
   Web of Science ®Google Scholar
• Taupin D, Lam W, Rangiah D, et al. A deleterious RNF43 germline mutation in a severely affected serrated polyposis kindred. Human Genome Variation. 2015;2:15013. doi:10.1038/hgv.2015.13
   Google Scholar
• Yan HHN, Lai JCW, Ho SL, et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut. 2017;66:1645–1656. doi:10.1136/gutjnl-2016-311849
   Web of Science ®Google Scholar
• Muller C, Yamada A, Ikegami S, et al. Risk of Colorectal cancer in serrated polyposis syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021. doi:10.1016/j.cgh.2021.05.057
   Web of Science ®Google Scholar
• Win AK, Walters RJ, Buchanan DD, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol. 2012;107:770–778. doi:10.1038/ajg.2012.52
   Web of Science ®Google Scholar
• Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59(9):1222–1225. doi:10.1136/gut.2009.200741
   Web of Science ®Google Scholar
• Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2013;62(3):404–408. doi:10.1136/gutjnl-2011-300514
   Web of Science ®Google Scholar
• Carballal S, Rodríguez-Alcalde D, Moreira L, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016;65(11):1829–1837. doi:10.1136/gutjnl-2015-309647
   Web of Science ®Google Scholar
• Bleijenberg AG, Je IJ, van Herwaarden YJ, et al. Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study. Gut. 2020;69:112–121. doi:10.1136/gutjnl-2018-318134
   Web of Science ®Google Scholar
• Hazewinkel Y, Reitsma JB, Nagengast FM, et al. Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives. Fam Cancer. 2013;12(4):669–673. doi:10.1007/s10689-013-9643-x
   Web of Science ®Google Scholar
• Edelstein DL, Cruz-Correa M, Soto-Salgado M, et al. Risk of colorectal and other cancers in patients with serrated polyposis. Clin Gastroenterol Hepatol. 2015;13(9):1697–1699. doi:10.1016/j.cgh.2015.02.003
   Web of Science ®Google Scholar
• Jasperson KW, Kanth P, Kirchhoff AC, et al. Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum. 2013;56(11):1211–1216. doi:10.1097/DCR.0b013e3182a11cca
   Web of Science ®Google Scholar
• Whitelaw SC, Murday VA, Tomlinson IP, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology. 1997;112:327–334. doi:10.1053/gast.1997.v112.pm9024286
   Web of Science ®Google Scholar
• Jaeger E, Leedham S, Lewis A, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;44:699–703. doi:10.1038/ng.2263
   Web of Science ®Google Scholar
• McKenna DB, Van Den Akker J, Zhou AY, et al. Identification of a novel GREM1 duplication in a patient with multiple colon polyps. Fam Cancer. 2019;18:63–66. doi:10.1007/s10689-018-0090-6
   Web of Science ®Google Scholar
• Rohlin A, Rambech E, Kvist A, et al. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing. Fam Cancer. 2017;16:195–203. doi:10.1007/s10689-016-9934-0
   PubMed Web of Science ®Google Scholar
• Lieberman S, Walsh T, Schechter M, et al. Features of patients with hereditary mixed polyposis syndrome caused by duplication of GREM1 and implications for screening and surveillance. Gastroenterology. 2017;152(1876–1880):e1871. doi:10.1053/j.gastro.2017.02.014
   Web of Science ®Google Scholar
• Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–262; quiz 263.
   Web of Science ®Google Scholar
• Monahan KJ, Bradshaw N, Dolwani S, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020;69:411–444. doi:10.1136/gutjnl-2019-319915
   Web of Science ®Google Scholar
• Wagner A, Aretz S, Auranen A, et al. The management of Peutz-Jeghers syndrome: European Hereditary Tumour Group (EHTG) Guideline. J Clin Med. 2021;10(3):473. doi:10.3390/jcm10030473
   PubMed Web of Science ®Google Scholar
• Jelsig AM, Bertelsen B, Forss I, Karstensen JG. Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome. Fam Cancer. 2020;20:55.
   Web of Science ®Google Scholar
• Spier I, Drichel D, Kerick M, et al. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases. J Med Genet. 2016;53:172–179. doi:10.1136/jmedgenet-2015-103468
   Web of Science ®Google Scholar
• Goldberg Y, Halpern N, Hubert A, et al. Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure. Cancer Genet. 2015;208(12):621–624. doi:10.1016/j.cancergen.2015.10.001
   Web of Science ®Google Scholar
• Spier I, Kerick M, Drichel D, et al. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis. Fam Cancer. 2016;15(2):281–288. doi:10.1007/s10689-016-9870-z
   PubMed Web of Science ®Google Scholar
• Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA. 2005;294:2465–2473. doi:10.1001/jama.294.19.2465
   PubMed Web of Science ®Google Scholar
• Tieu AH, Edelstein D, Axilbund J, et al. Clinical characteristics of multiple colorectal adenoma patients without germline APC or MYH mutations. J Clin Gastroenterol. 2016;50:584–588. doi:10.1097/MCG.0000000000000416
   Web of Science ®Google Scholar
• Kallenberg FGJ, Latchford A, Lips NC, et al. Duodenal adenomas in patients with multiple colorectal adenomas without germline APC or MUTYH mutations. Dis Colon Rectum. 2018;61:58–66. doi:10.1097/DCR.0000000000000868
   Web of Science ®Google Scholar
• Giarola M, Stagi L, Presciuttini S, et al. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat. 1999;13:116–123. doi:10.1002/(SICI)1098-1004(1999)13:2<116::AID-HUMU3>3.0.CO;2-2
   Web of Science ®Google Scholar
• NCCN. Available from: https://www.nccn.org. Accessed November 11, 2021.
   Google Scholar
• Wimmer K, Kratz CP, Vasen HF, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet. 2014;51(6):355–365.
   PubMed Web of Science ®Google Scholar